• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[诊断选项。适应症及有效性]

[Diagnostic options. Indications and validity].

作者信息

Stallmach A, Bürger M, Weber M

机构信息

Klinik für Innere Medizin IV (Gastroenterologie, Hepatologie und Infektiologie), Universitätsklinikum Jena, Friedrich-Schiller-Universität, Erlanger Allee 101, Jena, Deutschland,

出版信息

Internist (Berl). 2014 Aug;55(8):898-905. doi: 10.1007/s00108-013-3441-2.

DOI:10.1007/s00108-013-3441-2
PMID:24831680
Abstract

BACKGROUND

A variety of diagnostic methods provide the necessary rational basis for diagnosis, assessment of disease activity and exclusion of possible complications for patients with inflammatory bowel disease (IBD).

AIM

Currently, a wide range of diagnostic methods is available and easily accessible. The clinical use of all these different methods is inherently possible. As there is no reference test for either diagnosis or monitoring of IBD, diagnostic techniques must be selected, applied and interpreted in an appropriate clinical context. The objective is to evaluate the clinical, laboratory and imaging techniques including ultrasound and endoscopy in different clinical situations.

RESULTS

In addition to clinical parameters, fecal calprotectin and abdominal ultrasound are helpful tools to assess the inflammatory activity. In patients with high inflammatory activity, a routine endoscopy is not beneficial. At best, endoscopy can be performed to document the extent of mucosal inflammation before initiating an intensified immunosuppressive therapy. Knowledge and experience in the management and treatment of IBD complications are critical in providing a rational use of specific diagnostic methods.

CONCLUSION

As a basic principle, the critical evaluation of diagnostic methods in patients with IBD is of great importance. Specific clinical situations require specific diagnostic techniques. Every diagnostic method performed should have a purpose.

摘要

背景

多种诊断方法为炎症性肠病(IBD)患者的诊断、疾病活动度评估及可能并发症的排除提供了必要的合理依据。

目的

目前,有多种诊断方法可供使用且易于获取。所有这些不同方法在临床中都有可能应用。由于IBD的诊断或监测均无参考标准测试,因此必须在适当的临床背景下选择、应用和解读诊断技术。目的是评估包括超声和内镜检查在内的临床、实验室及影像学技术在不同临床情况下的应用。

结果

除临床参数外,粪便钙卫蛋白和腹部超声是评估炎症活动的有用工具。对于炎症活动度高的患者,常规内镜检查并无益处。至多,可在内镜检查在开始强化免疫抑制治疗前进行,以记录黏膜炎症的范围。IBD并发症管理和治疗方面的知识与经验对于合理使用特定诊断方法至关重要。

结论

作为基本原则,对IBD患者诊断方法进行批判性评估非常重要。特定临床情况需要特定诊断技术。所执行的每种诊断方法都应有其目的。

相似文献

1
[Diagnostic options. Indications and validity].[诊断选项。适应症及有效性]
Internist (Berl). 2014 Aug;55(8):898-905. doi: 10.1007/s00108-013-3441-2.
2
Diagnostic performance of rapid tests for detection of fecal calprotectin and lactoferrin and their ability to discriminate inflammatory from irritable bowel syndrome.用于检测粪便钙卫蛋白和乳铁蛋白的快速检测方法的诊断性能及其区分炎症性肠病和肠易激综合征的能力。
Clin Chem Lab Med. 2008;46(9):1275-80. doi: 10.1515/CCLM.2008.246.
3
Predicting inflammatory bowel disease in children with abdominal pain and diarrhoea: calgranulin-C versus calprotectin stool tests.预测腹痛和腹泻儿童的炎症性肠病:钙粒蛋白-C 与钙卫蛋白粪便检测。
Arch Dis Child. 2018 Jun;103(6):565-571. doi: 10.1136/archdischild-2017-314081. Epub 2018 Mar 7.
4
[The diagnosis of IBD must have a wide foundation].炎症性肠病的诊断必须有广泛的依据。
Lakartidningen. 2009;106(45):2984-6.
5
Selecting children with suspected inflammatory bowel disease for endoscopy with the calgranulin C or calprotectin stool test: protocol of the CACATU study.使用钙粒蛋白C或钙卫蛋白粪便检测选择疑似炎症性肠病儿童进行内镜检查:CACATU研究方案
BMJ Open. 2017 May 29;7(5):e015636. doi: 10.1136/bmjopen-2016-015636.
6
[Fecal Calprotectin in Inflammatory Bowel Disease].[粪便钙卫蛋白在炎症性肠病中的作用]
Korean J Gastroenterol. 2016 May 25;67(5):233-7. doi: 10.4166/kjg.2016.67.5.233.
7
Safely ruling out inflammatory bowel disease in children and teenagers without referral for endoscopy.安全排除儿童和青少年炎症性肠病,无需转介内镜检查。
Arch Dis Child. 2012 Dec;97(12):1014-8. doi: 10.1136/archdischild-2011-301206. Epub 2012 Sep 27.
8
Noninvasive testing in the management of children with suspected inflammatory bowel disease.疑似炎症性肠病患儿管理中的无创检测
Scand J Gastroenterol. 2019 May;54(5):586-591. doi: 10.1080/00365521.2019.1604799. Epub 2019 Apr 28.
9
Diagnostic work-up of inflammatory bowel disease in children: the role of calprotectin assay.儿童炎症性肠病的诊断工作:钙卫蛋白检测的作用。
Inflamm Bowel Dis. 2010 Nov;16(11):1926-30. doi: 10.1002/ibd.21257.
10
Faecal calprotectin for screening of patients with suspected inflammatory bowel disease: diagnostic meta-analysis.粪便钙卫蛋白用于疑似炎症性肠病患者的筛查:诊断性荟萃分析。
BMJ. 2010 Jul 15;341:c3369. doi: 10.1136/bmj.c3369.

本文引用的文献

1
Crohn's disease and ulcerative colitis. Occurrence, course and prognosis during the first year of disease in a European population-based inception cohort.克罗恩病和溃疡性结肠炎。欧洲一项基于人群的起始队列研究中疾病第一年的发病率、病程及预后
Dan Med J. 2014 Jan;61(1):B4778.
2
Incidence and clinical course of Crohn's disease during the first year - results from the IBD Cohort of the Uppsala Region (ICURE) of Sweden 2005-2009.2005-2009 年瑞典乌普萨拉地区炎症性肠病队列(ICURE)研究:第一年克罗恩病的发病情况及临床病程。
J Crohns Colitis. 2014 Mar;8(3):215-22. doi: 10.1016/j.crohns.2013.08.009. Epub 2013 Sep 12.
3
European consensus on the histopathology of inflammatory bowel disease.
欧洲炎症性肠病组织病理学共识。
J Crohns Colitis. 2013 Nov;7(10):827-51. doi: 10.1016/j.crohns.2013.06.001. Epub 2013 Jul 17.
4
Imaging techniques for assessment of inflammatory bowel disease: joint ECCO and ESGAR evidence-based consensus guidelines.炎症性肠病评估的影像学技术:ECCO 和 ESGAR 联合循证共识指南。
J Crohns Colitis. 2013 Aug;7(7):556-85. doi: 10.1016/j.crohns.2013.02.020. Epub 2013 Apr 11.
5
Exploring the use of adalimumab for patients with moderate Crohn's disease: subanalyses from induction and maintenance trials.探讨阿达木单抗在中度克罗恩病患者中的应用:来自诱导和维持试验的亚组分析。
J Crohns Colitis. 2013 Dec;7(12):958-67. doi: 10.1016/j.crohns.2013.02.016. Epub 2013 Mar 18.
6
Repeat stool testing for Clostridium difficile using enzyme immunoassay in patients with inflammatory bowel disease increases diagnostic yield.在炎症性肠病患者中,使用酶联免疫吸附试验重复检测艰难梭菌可提高诊断率。
Curr Med Res Opin. 2012 Sep;28(9):1553-60. doi: 10.1185/03007995.2012.717529. Epub 2012 Aug 23.
7
C-reactive protein, an indicator for maintained response or remission to infliximab in patients with Crohn's disease: a post-hoc analysis from ACCENT I.C 反应蛋白可作为克罗恩病患者对英夫利昔单抗维持应答或缓解的指标:ACCENT I 事后分析。
Aliment Pharmacol Ther. 2012 Mar;35(5):568-76. doi: 10.1111/j.1365-2036.2011.04987.x. Epub 2012 Jan 18.
8
Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review.基于系统评价,炎症性肠病的发病率和患病率随时间逐渐增加。
Gastroenterology. 2012 Jan;142(1):46-54.e42; quiz e30. doi: 10.1053/j.gastro.2011.10.001. Epub 2011 Oct 14.
9
[Updated German guideline on diagnosis and treatment of ulcerative colitis, 2011].[2011年德国溃疡性结肠炎诊断与治疗更新指南]
Z Gastroenterol. 2011 Sep;49(9):1276-341. doi: 10.1055/s-0031-1281666. Epub 2011 Aug 24.
10
Evaluation of disease activity in IBD at the time of diagnosis by the use of clinical, biochemical, and fecal markers.在诊断时通过临床、生化和粪便标志物评估炎症性肠病的疾病活动度。
Scand J Gastroenterol. 2011 Sep;46(9):1081-91. doi: 10.3109/00365521.2011.584897. Epub 2011 May 30.